[Federal Register Volume 75, Number 169 (Wednesday, September 1, 2010)]
[Notices]
[Pages 53719-53720]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-21745]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 29, 2010, Cambrex 
Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of Gamma Hydroxybutyric Acid (GHB) 
(2010), a basic class of controlled substance listed in schedule I.
    The company plans to manufacture Gamma Hydroxybutyric Acid (GHB) 
(2010) in bulk active pharmaceutical ingredient (API) form for 
distribution to the company's customers.
    Any other such applicant, and any person who is presently 
registered with

[[Page 53720]]

DEA to manufacture such substances, may file comments or objections to 
the issuance of the proposed registration pursuant to 21 CFR 
1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than November 1, 2010.

    Dated: August 13, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-21745 Filed 8-31-10; 8:45 am]
BILLING CODE 4410-09-P